Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,586 | 3,406 | 12,829 | 9,155 | 5,728 |
| Depreciation Amortization | 370 | 183 | 671 | 1,364 | 928 |
| Income taxes - deferred | -1,066 | 79 | 57 | -227 | -145 |
| Accounts receivable | 2,021 | 1,561 | -8,241 | -5,571 | -3,296 |
| Accounts payable and accrued liabilities | 1,709 | 105 | 1,125 | 37 | -16 |
| Other Working Capital | -175 | 178 | -5,056 | -4,329 | -4,048 |
| Other Operating Activity | -2,286 | -865 | 8,659 | 6,575 | 3,914 |
| Operating Cash Flow | $8,160 | $4,646 | $10,043 | $7,004 | $3,065 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 500 | 500 | 500 |
| PPE Investments | -6,935 | -6,557 | -1,875 | -1,403 | -847 |
| Investing Cash Flow | $-6,935 | $-6,557 | $-1,375 | $-903 | $-347 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7 | N/A | 147 | 147 | 72 |
| Dividend Paid | -13,223 | -13,223 | -12,559 | -12,559 | -12,559 |
| Other Financing Activity | -147 | -50 | -294 | -96 | -73 |
| Financing Cash Flow | $-13,363 | $-13,273 | $-12,706 | $-12,508 | $-12,560 |
| Beginning Cash Position | 57,961 | 57,961 | 62,000 | 62,000 | 62,000 |
| End Cash Position | 45,823 | 42,777 | 57,961 | 55,592 | 52,158 |
| Net Cash Flow | $-12,138 | $-15,184 | $-4,039 | $-6,407 | $-9,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,160 | 4,646 | 10,043 | 7,004 | 3,065 |
| Capital Expenditure | -6,935 | -6,557 | -1,875 | -1,403 | -847 |
| Free Cash Flow | 1,225 | -1,911 | 8,168 | 5,601 | 2,218 |